小松田 浩樹

Prognostic Value of the 18F-FDG PET/CT and Haematological Parameters in Head and Neck Cancer. 

Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery 49(6) 733-741 2024年11月  

Combined approach for predicting the efficacy of nivolumab in head and neck carcinoma by tissue and soluble expressions of PD-L1 and PD-L2. 

Head & neck 46(9) 2233-2243 2024年9月  

Hypoxia-Targeted Immunotherapy with PD-1 Blockade in Head and Neck Cancer. 

Cancers 16(17) 2024年8月29日  

Immunotherapy targeting tumor-associated antigen in a mouse model of head and neck cancer. 

Head & neck 46(8) 2056-2067 2024年8月  

A comparison of the clinical efficacy of tonsillectomy with steroid pulse therapy and tonsillectomy therapy alone for patients with immunoglobulin A nephropathy: a retrospective observational study. 

Clinical and experimental nephrology 2024年6月18日  

Soluble CD27 as a predictive biomarker for intra-tumoral CD70/CD27 interaction in nasopharyngeal carcinoma. 

Cancer science 115(4) 1073-1084 2024年4月  

Exploring Immunological Effects and Novel Immune Adjuvants in Immunotherapy for Salivary Gland Cancers. 

Cancers 16(6) 2024年3月19日  

Efficacy of Cetuximab Combined with Paclitaxel in Patients with Recurrent Salivary Gland Carcinoma: A Retrospective Observational Study. 

ORL; journal for oto-rhino-laryngology and its related specialties 86(1) 41-49 2024年  

Common Characteristics of Sinonasal Inflammation Associated with IgG4-Related Disease and Other Chronic Inflammatory Diseases: A Retrospective Observational Study. 

ORL; journal for oto-rhino-laryngology and its related specialties 86(2) 95-100 2024年  

Harnessing Immunity to Treat Advanced Thyroid Cancer. 

Vaccines 12(1) 2023年12月30日  

Sensory trick in patients with opsoclonus-myoclonus syndrome. 

Acta neurologica Belgica 123(6) 2353-2355 2023年12月  

Central-part laryngectomy after laryngotracheal separation to manage pharyngocutaneous fistula: A case report and retrospective analysis of 12 cases. 

Auris, nasus, larynx 50(4) 628-631 2023年8月  

Brachyury-targeted immunotherapy combined with gemcitabine against head and neck cancer. 

Cancer immunology, immunotherapy : CII 72(8) 2799-2812 2023年8月  

Expression of soluble CD27 in extranodal natural killer/T-cell lymphoma, nasal type: potential as a biomarker for diagnosis and CD27/CD70-targeted therapy. 

Cancer immunology, immunotherapy : CII 72(7) 2087-2098 2023年7月  

Celecoxib promotes the efficacy of STING-targeted therapy by increasing antitumor CD8+ T-cell functions via modulating glucose metabolism of CD11b+ Ly6G+ cells. 

International journal of cancer 152(8) 1685-1697 2023年4月15日